DRAPER, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, has earned two Golden Globee® awards at the 2024 Globee® Awards for Technology, including the Golden Globee® for Achievement in Leadership of Technology Strategy and Chief Technology Officer of the Year honors for Executive Vice President and Chief Technology Officer, Eli Rosner. Both awards noted HealthEquity’s early leadership in deployment of real-world applications of AI.
“Our teammates believe innovation can serve our mission to save and improve lives by empowering healthcare consumers,” said Rosner. “For example, when someone is sick or injured, the last thing they want to worry about is access to their healthcare account, so we built our AI claims processing tool to speed up claims and minimize error, allowing our members to focus less time on their bills and more time on their health.”
The Globee® Awards, which highlight achievements in various industries, are known for their rigorous judging process. The judging panel includes industry experts from a wide range of fields, ensuring that each entry is evaluated fairly and comprehensively. The Globee® Awards for Technology honor and celebrate the achievements and positive contributions of organizations and individuals from all over the world.
HealthEquity’s deployment of AI in service of its mission continues as this year’s open enrollment season gets underway. The recent launch of HSAnswers, an AI-driven tool, provides answers for both simple and complex questions regarding HSAs and other consumer-directed benefits. More innovations are in the works. New tools that customize benefits for member’s individual needs, seamless payment integrations, and tech enhancements that help members take proactive steps to support their health and wealth are just a few areas HealthEquity teammates are working to improve.
"Health benefits can be complicated,” said Rosner. "We are looking for pain points in every aspect of the benefits journey – such as building a benefits plan, checking if a service is covered, or making the best selections for your family – and working to build tools that will empower our members to access and take charge of their healthcare.”
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 16 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission of saving and improving lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our “Purple service” and approach at www.healthequity.com.
Media Contact:
Amy Cerny, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$94.76 |
Daily Change: | 3.22 3.52 |
Daily Volume: | 1,041,470 |
Market Cap: | US$8.210B |
November 12, 2024 October 15, 2024 September 03, 2024 September 03, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB